A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
| Autor: | Berkovsky A; Institute of Blood Transfusion, Scientific Research Centre of Haematology, Moscow, Russia. aron@blood.ru, Sergeeva EV, Suvorov AV, Uljavova IS, Kachalova ND, Klimovich LG, Samsonova NN, Kozlov AA |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2006; Vol. 44 (10), pp. 1214-7. |
| DOI: | 10.1515/CCLM.2006.217 |
| Abstrakt: | Background: Oral anticoagulant therapy is monitored by a prothrombin time (PT) assay. The PT is standardised by the International Normalised Ratio (INR). The purpose of this study was to work out a modified method of PT/INR measurement in capillary blood for monitoring anticoagulation treatment. Methods: Healthy donors, subjects with high or low haematocrit values, and oral anticoagulant-treated patients were included in the study. Plasma and capillary blood PT/INRs were determined by the standard Quick clotting assay, by the modified approach and with the CoaguChek S analyser. Results: The performance characteristics of the developed method were accuracy, due to taking into account whole capillary blood haematocrit values, and precision, due to a decrease in the viscosity of the analysed samples. Implementation of the modified method showed that it is possible to use PT values of normal plasma for capillary blood INR calculation. The developed method allowed the determination of PT in capillary blood within the haematocrit value range from 0.15 up to 0.7. For capillary blood, the results of the modified method closely correlated with PT/INR values determined by the reference Quick method in venous plasma (r=0.99) and with the CoaguChek S analyser (r=0.97). Conclusions: The modified method of capillary blood PT/INR determination could be recommended for oral anticoagulant therapy monitoring. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|